Tag: Lancet
Cartesian Therapeutics Announces Landmark Study in The Lancet Neurology of First…...
Modifying patients' T-cells with mRNA to express a chimeric antigen receptor (rCAR-T therapy) a novel approach to treat myasthenia gravis and other autoimmune...
The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs...
NORTH CHICAGO, Ill., May 27, 2022 /PRNewswire/ -- AbbVie ABBV today announced The Lancet published results from three pivotal Phase 3 clinical trials – U-ACHIEVE (induction),...
Vollständige Ergebnisse nach 72 Wochen der Phase-3-HOPE-Studie zu Oxbryta® (Voxelotor) Tabletten in...
SOUTH SAN FRANCISCO, Kalifornien, April 09, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) hat heute bekanntgegeben, dass...
Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor)...
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced The Lancet...